Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS · Delayed Price · Currency is USD
0.147
-0.003 (-2.00%)
Apr 29, 2026, 1:05 PM EST

KBLB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
1669396403278
Upgrade
Market Cap Growth
82.28%-3.77%140.82%25.13%-58.95%-27.40%
Upgrade
Enterprise Value
17198102443584
Upgrade
Last Close Price
0.150.090.090.040.030.08
Upgrade
PB Ratio
-20.73-11.59-11.82-7.01-9.07-14.70
Upgrade
Debt / Equity Ratio
-0.21-0.21-0.21-0.31-0.50-0.46
Upgrade
Net Debt / Equity Ratio
0.020.02-0.130.140.62-0.01
Upgrade
Net Debt / EBITDA Ratio
0.040.04-0.340.311.05-0.02
Upgrade
Net Debt / FCF Ratio
0.070.07-0.560.641.16-0.03
Upgrade
Quick Ratio
0.170.170.070.290.490.29
Upgrade
Current Ratio
0.180.180.080.290.490.29
Upgrade
Return on Assets (ROA)
-103.63%-103.63%-81.11%-41.88%-34.92%-80.23%
Upgrade
Return on Capital Employed (ROCE)
42.80%42.80%37.90%46.30%60.60%53.70%
Upgrade
Earnings Yield
-2.19%-3.91%-3.53%-7.58%-12.02%-10.33%
Upgrade
FCF Yield
-1.08%-1.94%-1.91%-3.13%-5.92%-2.44%
Upgrade
Buyback Yield / Dilution
-2.03%-2.03%-0.51%-6.04%-11.02%-3.41%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.